How have PAS shares performed in 2024?

Pascal Biosciences' stock was trading at C$0.02 at the start of the year. Since then, PAS shares have increased by 0.0% and is now trading at C$0.02. View the best growth stocks for 2024 here .

What other stocks do shareholders of Pascal Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pascal Biosciences investors own include Aurora Cannabis (ACB) , Canadian Natural Resources (CNQ) , Corus Entertainment (CJR) , Auxly Cannabis Group (CBWTF) , Grande West Transportation Group (BUS) , Bausch Health Companies (BHC) , Abattis Bioceuticals (ATT) , Algonquin Power & Utilities (AQN) , Aphria (APHA) and Abacus Mining & Exploration (AME) .

How do I buy shares of Pascal Biosciences?

Shares of PAS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor , Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Compare Top Brokerages Here .

CVE:PAS

Pascal Biosciences (PAS) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Free PAS Stock Alerts

C$0.02

-0.01 (-25.00%)

(As of 12/5/2022)

Compare

Today's Range: C$0.02
▼
C$0.02
50-Day Range: C$0.02
▼
C$0.02
52-Week Range: C$0.02
▼
C$0.10

Volume: 4,000 shs
Average Volume: 52,289 shs
Market Capitalization: C$983,850.00

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Pascal Biosciences alerts:

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About Pascal Biosciences Stock (CVE:PAS)

Pascal Biosciences Inc., a biotechnology company, engages in the research and development of products for the treatment of cancer, and for the improvement of the immune system. The company's development portfolio includes PAS-403, a mitosis inhibitor that blocks cell division for the treatment of glioblastoma and brain metastases originating from other cancers; and PAS-393, an immune-stimulatory cannabinoid designed to restore the immunogenicity of tumor cells with checkpoint inhibitor therapy for use in cancer treatment. It is also developing a B-cell targeted antibody for acute lymphoblastic leukemia and B cell lymphomas; and cannabinoid therapeutic products for the treatment of COVID-19. The company has an exclusive license agreement with the University of Washington to develop a cannabinoid-based product for the treatment of glioblastoma multiforme and brain metastases; and a collaborative research agreement with SoRSE Technology Corporation to advance PAS-393 into clinical testing. Pascal Biosciences Inc. was incorporated in 2011 and is headquartered in Seattle, Washington.

PAS Stock Price History

30 days | 90 days | 365 days | Advanced Chart

PAS Stock News Headlines

April 19, 2024 | sports.yahoo.com

Pacers forward Pascal Siakam discusses Indiana's return to the playoffs.

April 19, 2024 | msn.com

Columbus Blue Jackets 2023-24 review: 3 reasons to keep coach Pascal Vincent

April 19, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

April 19, 2024 | yahoo.com

15 pics proving Sarah Paulson & Pedro Pascal are an iconic bestie duo

April 19, 2024 | sportsbookwire.usatoday.com

Pascal Siakam Player Prop Bets: Pacers vs. Bucks | April 21

April 17, 2024 | msn.com

Spider-Man 4 with Zendaya, Tom Holland gets funny Amy Pascal update

April 16, 2024 | msn.com

Gladiator 2 Sounds Like It'll Continue The 25-Year Pedro Pascal Calling Card That We're Finally Getting Sick Of

April 14, 2024 | usatoday.com

Pascal Siakam discusses the Pacers win over Atlanta and return to the NBA Playoffs.

April 19, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

April 14, 2024 | sportsbookwire.usatoday.com

Pascal Siakam Player Prop Bets: Pacers vs. Hawks | April 14

April 14, 2024 | msn.com

Most Fans Haven't Even Seen Footage Of Gladiator 2 Yet, And They're Already Having The Best Reactions To Paul Mescal, Pedro Pascal And Joseph Quinn

April 13, 2024 | thetimes.co.uk

L&G fires warning shot at AstraZeneca over Pascal Soriot pay

April 12, 2024 | msn.com

Pedro Almodóvar’s Queer Cowboy Movie Starring Pedro Pascal Is Now Streaming on Netflix

April 12, 2024 | msn.com

‘Strange Way of Life’ on Netflix: Pedro Pascal and Ethan Hawke’s Gay Western Is Romantic AF

April 12, 2024 | sportsbookwire.usatoday.com

Pascal Siakam Player Prop Bets: Pacers vs. Cavaliers | April 12

April 11, 2024 | theguardian.com

The danger in saying yes to Pascal Soriot’s pay rise at AstraZeneca

April 10, 2024 | thetimes.co.uk

Proxy advisers join Sir Pascal Soriot in the spotlight

April 10, 2024 | msn.com

Amy Pascal & Kevin Feige Didn’t Know Who Zendaya Was Before Spider-Man Casting

April 10, 2024 | msn.com

Tyrese Haliburton, Pascal Siakam power the Pacers to a 140-123 win over the Raptors

April 10, 2024 | msn.com

‘Spider-Man’ Producer Amy Pascal Admits Not Knowing Who Zendaya Was When She Auditioned For MJ

April 6, 2024 | mirror.co.uk

Inside Pedro Pascal's dating history as Game of Thrones and The Last Of Us star turns 49

April 5, 2024 | msn.com

Pascal Vincent Gives Injury Update

April 4, 2024 | msn.com

Tom Cruise, Pedro Pascal, Emma Stone and ‘Godzilla Minus One’ Among Critics Choice Super Awards Winners

April 4, 2024 | msn.com

Tom Cruise, Pedro Pascal, Emma Stone and ‘Godzilla Minus One' Among Critics Choice Super Awards Winners

April 3, 2024 | msn.com

Zach Werenski Gave His Opinions On Head Coach Pascal Vincent, Daniil Tarasov Today On 97.1 The Fan

April 3, 2024 | msn.com

Zach Werenski Gives His Opinions On Head Coach Pascal Vincent, Daniil Tarasov Today On 97.1 The Fan

April 3, 2024 | msn.com

Happy Birthday Pedro Pascal: From Family Tragedy to Global Stardom at 49

See More Headlines

Receive PAS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pascal Biosciences and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: CVE
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: CVE:PAS
CUSIP: N/A
CIK: N/A
Web: www.biommune.net
Phone: +1-604-6886775
Fax: N/A
Employees: 6
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): C($0.01)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: -340.40%

Debt

Debt-to-Equity Ratio: 882.79
Current Ratio: 0.03
Quick Ratio: 0.17

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: C$0.00 per share
Price / Cash Flow: 55.00
Book Value: C($0.02) per share
Price / Book: -0.75

Miscellaneous

Outstanding Shares: 65,590,000
Free Float: N/A
Market Cap: C$983,850.00
Optionable: Not Optionable
Beta: 1.51

Beginner's Guide to Pot Stock Investing

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

Mr. Harold H. Forzley C.A. (Age 69)
Chief Financial Officer
Comp: $16.8k
Dr. Brian W. Bapty Ph.D. (Age 53)
CEO, Pres & Director
Mr. Kevin M. Egan M.B.A.
Chief Bus. Officer

Key Competitors

View All Competitors

PAS Stock Analysis - Frequently Asked Questions

How have PAS shares performed in 2024?: Pascal Biosciences' stock was trading at C$0.02 at the start of the year. Since then, PAS shares have increased by 0.0% and is now trading at C$0.02.
View the best growth stocks for 2024 here.
What other stocks do shareholders of Pascal Biosciences own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Pascal Biosciences investors own include Aurora Cannabis (ACB), Canadian Natural Resources (CNQ), Corus Entertainment (CJR), Auxly Cannabis Group (CBWTF), Grande West Transportation Group (BUS), Bausch Health Companies (BHC), Abattis Bioceuticals (ATT), Algonquin Power & Utilities (AQN), Aphria (APHA) and Abacus Mining & Exploration (AME).
How do I buy shares of Pascal Biosciences?: Shares of PAS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:PAS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Pascal Biosciences (PAS) Stock Price, News & Analysis

About Pascal Biosciences Stock (CVE:PAS)

PAS Stock Price History

PAS Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

PAS Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info